dwaldman
True Blue
20600 Arthrocentesis, aspiration and/or injection, small joint or bursa (eg, fingers, toes); without ultrasound guidance
20604 with ultrasound guidance, with permanent recording and reporting
(Do not report 20600, 20604 in conjunction with 76942)
(If fluoroscopic, CT, or MRI guidance is performed, see 77002, 77012, 77021)
20605 Arthrocentesis, aspiration, and/or injection, intermediate joint or bursa (eg, temporomandibular, acormioclavicular, wrist, elbow, or ankle, olecranon bursa); without ultrasound guidance
20606 with ultrasound guidance, with permanent recording and reporting
(Do not report 20605, 20606 in conjunction with 76942)
(If fluoroscopic, CT, or MRI guidance is performed, see 77002, 77012, 77021)
20610 Arthrocentesis, aspiration and/or injection, major joint or bursa (eg, shoulder hip, knee, subacromial bursa); without ultrasound guidance
20611 with ultrasound guidance, with permanent recording and reporting
Do not report 20610, 20611 in conjunction with 76942)
(If fluoroscopic, CT, or MRI guidance is performed, see 77002, 77012, 77021)
22510 Percutaneous Vertebroplasty (bone biopsy included when performed) 1 vertebral body, unilateral or bilateral injection, inclusive of all imaging guidance, cervicothoracic
22511 lumbosacral
22512 each additional cervothroacic or lumbosacral, vertebral body (List separately in addition to code for primary procedure)
(Use 22512 in conjunction with 22510, 22511)
(Do not report 22510, 22511, 22512 in conjunction with 20225, 22310, 22325, 22327 when performed at the same level as 22510, 22511, 22512_
225213 Percutaneous vertebral augmentation, including cavity creation (fracture reduction and bone biopsy included with performed) using mechanical device (eg, Kyphoplasty) 1 vertebral body, unilateral or bilateral cannulation, inclusive of all imaging guidance
22514 lumbar
22515 each additional thoracic or lumbar vertebral body (List separately in addition to code for primary procedure)
(Use 22515 in conjunction with 22513, 22514)
(Do not report 22513, 22514, 22515 in conjunction with 20225, 22310, 22315, 22325, 22327 when performed at the same level as 22513, 22514 ,22515)
62284 Injection procedure for myelography and/or computed tomography, lumbar (other than C1-C2 and posterior fosa)
(Do not report 62284 in conjunction with 62302,62303,62304, 62305, 72240, 72255, 72265, 77270)
62302 Myleography via lumbar injection, including radiological supervision and interpretation; cervical
62303 thoracic
62304 lumbosacral
62305 2 or more regions (eg lumbar/thoracic, cervical/thoracic, lumbar/cervical, lumbar/thoracic/cervical)
76942 Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, location device,), imaging supervision and interpretation
(Do not report 76942 in conjunction with 10030, 19083, 19285, 20604, 20606, 20611, 27096, 322554, 32555, 32556, 32557, 37760, 37761, 43232, 43237, 43242, 45341, 45342, 64479-64484, 64490-64495, 76972, 2013T-0218T, 0228T-0231T, 0232T , 0249T, 0301T)
72265 Myleography, lumbosacral, radiological supervision and interpretation
(When both 62284 and 72265 are performed by the same physician or other qualified health care professional for lumbosacral myelography, use 62304)
Presumptive Drug Class Screening
80300 Drug screen, any number of drug classes from Drug Class List A, any number of non-TLC devices or procedures (eg, immunoassay) capable of being read by direct optical observation, including instrumented-assisted with performed (eg, dipsticks, cups, cards ,cartirdiges) per date of service
80301 single drug class method, by instrumented test systems, (eg, discrete multichannel chemistry analyzers utilizing immunoassay or enzyme assay), per date of service
80302 Drug screen presumptive, single drug class from Drug Class List B, by immunoassay (eg, ELSIA) or non-TLC chromography without mass spectrometry (eg, GC, HPLC), each procedure
80303 Drug screen, any number of drug classes persumtive, single or mutple drug class method; thin layer chromatography procedure(s) (TLC) (eg, acid, neutral alkaloid plate)per date of service
80304 not otherwise specified presumptive procedures (eg, TOF, MALDI, LDTD, DESI, DART) each procedure
Definitive Drug Testing
(Use 80320-80377 to report definitive drug class procedures. Definitive testing may be qualitative, quantitative, or a combination of qualitative and quantitative for the same patient on the same date of service
82541 Column chromathography/mass spectrometry (eg GC/MS or HPLC/MS) non-drug anaylte not elsewhere specified qualitative single stionary and mobile phase
82542
82543
82544
(For column chromatography/mass spectrometry fof drugs or substances, see Drug Assay 80300, 80301 ,80302 80303 80304 80320-80377 or specific analyte code(s) in the Chemsitry section.
20604 with ultrasound guidance, with permanent recording and reporting
(Do not report 20600, 20604 in conjunction with 76942)
(If fluoroscopic, CT, or MRI guidance is performed, see 77002, 77012, 77021)
20605 Arthrocentesis, aspiration, and/or injection, intermediate joint or bursa (eg, temporomandibular, acormioclavicular, wrist, elbow, or ankle, olecranon bursa); without ultrasound guidance
20606 with ultrasound guidance, with permanent recording and reporting
(Do not report 20605, 20606 in conjunction with 76942)
(If fluoroscopic, CT, or MRI guidance is performed, see 77002, 77012, 77021)
20610 Arthrocentesis, aspiration and/or injection, major joint or bursa (eg, shoulder hip, knee, subacromial bursa); without ultrasound guidance
20611 with ultrasound guidance, with permanent recording and reporting
Do not report 20610, 20611 in conjunction with 76942)
(If fluoroscopic, CT, or MRI guidance is performed, see 77002, 77012, 77021)
22510 Percutaneous Vertebroplasty (bone biopsy included when performed) 1 vertebral body, unilateral or bilateral injection, inclusive of all imaging guidance, cervicothoracic
22511 lumbosacral
22512 each additional cervothroacic or lumbosacral, vertebral body (List separately in addition to code for primary procedure)
(Use 22512 in conjunction with 22510, 22511)
(Do not report 22510, 22511, 22512 in conjunction with 20225, 22310, 22325, 22327 when performed at the same level as 22510, 22511, 22512_
225213 Percutaneous vertebral augmentation, including cavity creation (fracture reduction and bone biopsy included with performed) using mechanical device (eg, Kyphoplasty) 1 vertebral body, unilateral or bilateral cannulation, inclusive of all imaging guidance
22514 lumbar
22515 each additional thoracic or lumbar vertebral body (List separately in addition to code for primary procedure)
(Use 22515 in conjunction with 22513, 22514)
(Do not report 22513, 22514, 22515 in conjunction with 20225, 22310, 22315, 22325, 22327 when performed at the same level as 22513, 22514 ,22515)
62284 Injection procedure for myelography and/or computed tomography, lumbar (other than C1-C2 and posterior fosa)
(Do not report 62284 in conjunction with 62302,62303,62304, 62305, 72240, 72255, 72265, 77270)
62302 Myleography via lumbar injection, including radiological supervision and interpretation; cervical
62303 thoracic
62304 lumbosacral
62305 2 or more regions (eg lumbar/thoracic, cervical/thoracic, lumbar/cervical, lumbar/thoracic/cervical)
76942 Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, location device,), imaging supervision and interpretation
(Do not report 76942 in conjunction with 10030, 19083, 19285, 20604, 20606, 20611, 27096, 322554, 32555, 32556, 32557, 37760, 37761, 43232, 43237, 43242, 45341, 45342, 64479-64484, 64490-64495, 76972, 2013T-0218T, 0228T-0231T, 0232T , 0249T, 0301T)
72265 Myleography, lumbosacral, radiological supervision and interpretation
(When both 62284 and 72265 are performed by the same physician or other qualified health care professional for lumbosacral myelography, use 62304)
Presumptive Drug Class Screening
80300 Drug screen, any number of drug classes from Drug Class List A, any number of non-TLC devices or procedures (eg, immunoassay) capable of being read by direct optical observation, including instrumented-assisted with performed (eg, dipsticks, cups, cards ,cartirdiges) per date of service
80301 single drug class method, by instrumented test systems, (eg, discrete multichannel chemistry analyzers utilizing immunoassay or enzyme assay), per date of service
80302 Drug screen presumptive, single drug class from Drug Class List B, by immunoassay (eg, ELSIA) or non-TLC chromography without mass spectrometry (eg, GC, HPLC), each procedure
80303 Drug screen, any number of drug classes persumtive, single or mutple drug class method; thin layer chromatography procedure(s) (TLC) (eg, acid, neutral alkaloid plate)per date of service
80304 not otherwise specified presumptive procedures (eg, TOF, MALDI, LDTD, DESI, DART) each procedure
Definitive Drug Testing
(Use 80320-80377 to report definitive drug class procedures. Definitive testing may be qualitative, quantitative, or a combination of qualitative and quantitative for the same patient on the same date of service
82541 Column chromathography/mass spectrometry (eg GC/MS or HPLC/MS) non-drug anaylte not elsewhere specified qualitative single stionary and mobile phase
82542
82543
82544
(For column chromatography/mass spectrometry fof drugs or substances, see Drug Assay 80300, 80301 ,80302 80303 80304 80320-80377 or specific analyte code(s) in the Chemsitry section.